Characterization of CD56bright NK cells in Daclizumab HYP-treated RRMS patients

被引：0
|
作者：
Huss, David J. [1 ]
Fragoso, Maria F. [1 ]
Cullen, Patrick [2 ]
Allaire, Norm [2 ]
Fontenot, Jason D. [1 ]
机构：
[1] Biogen Idec Inc, Immunol Res, Cambridge, MA USA
[2] Biogen Idec Inc, Genet & Genom, Cambridge, MA USA
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2014年 / 275卷 / 1-2期
关键词：
D O I：
10.1016/j.jneuroim.2014.08.230
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
213
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [1] CD56bright Natural Killer Cell Expansion Predicts Response to Daclizumab HYP Treatment in RRMS: Results of the SELECT Trial
    Elkins, Jacob
    Sheridan, James
    Amaravadi, Lakshmi
    Riester, Katherine
    O'Neill, Gilmore
    NEUROLOGY, 2012, 78
  • [2] Expansion of CD56bright NK cells correlates with therapeutic response to daclizumab in multiple sclerosis
    Sheridan, J.
    Elkins, J.
    Zhang, Y.
    Riester, K.
    O'Neill, G.
    Lambert, P.
    Fong, A.
    Tang, M.
    Vexler, V.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S123 - S123
  • [3] Prediction and Characterization of CD56bright NK Cell Expansion during Daclizumab Treatment for Multiple Sclerosis
    Sheridan, James
    Zhang, Ying
    Riester, Katherine
    O'Neill, Gilmore
    Tang, Meina T.
    Elkins, Jacob
    NEUROLOGY, 2010, 74 (09) : A371 - A371
  • [4] Human CD56bright NK Cells: An Update
    Michel, Tatiana
    Poli, Aurelie
    Cuapio, Angelica
    Briquemont, Benjamin
    Iserentant, Gilles
    Ollert, Markus
    Zimmer, Jacques
    JOURNAL OF IMMUNOLOGY, 2016, 196 (07): : 2923 - 2931
  • [5] CD56BRIGHT NK CELLS: 'NATURAL INFLAMMATORY CELLS'?
    Dalbeth, N.
    Gundle, R.
    Davies, R.
    Callan, M.
    RHEUMATOLOGY, 2004, 43 : 132 - 132
  • [6] CD56bright NK cells: 'Natural inflammatory cells'?
    Dalbeth, N
    Callan, M
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S267 - S267
  • [7] Characterization of CD56bright NK cells which inversely correlate with survival of melanoma patients
    de Jonge, Kaat
    Ebering, Anna
    Nassiri, Sina
    Baumgartner, Petra
    Speiser, Daniel E.
    SWISS MEDICAL WEEKLY, 2018, 148 : 39S - 40S
  • [8] The role of CD56bright NK cells in neurodegenerative disorders
    Rodriguez-Mogeda, Carla
    van Ansenwoude, Chaja M. J.
    van der Molen, Lennart
    Strijbis, Eva M. M.
    Mebius, Reina E.
    de Vries, Helga E.
    JOURNAL OF NEUROINFLAMMATION, 2024, 21 (01)
  • [9] The role of CD56bright NK cells in neurodegenerative disorders
    Carla Rodriguez-Mogeda
    Chaja M. J. van Ansenwoude
    Lennart van der Molen
    Eva M. M. Strijbis
    Reina E. Mebius
    Helga E. de Vries
    Journal of Neuroinflammation, 21
  • [10] Daclizumab Therapy Effectively Blocks CD25 and Expands Immunoregulatory CD56bright NK Cells in the Intrathecal Compartment
    Bielekova, Bibiana
    Azita, Kashani
    Ohayon, Joan
    Heman, Matt
    Richert, Nancy
    Blevins, Gregg
    NEUROLOGY, 2011, 76 (09) : A136 - A136
12345